Evidence map›Paper›PMID 29625127›Full record

ArticleInternational journal for parasitology2018

Toxoplasma CRISPR/Cas9 constructs are functional for gene disruption in Neospora caninum.

David Arranz-Solís, Javier Regidor-Cerrillo, Sebastian Lourido, Luis Miguel Ortega-Mora, Jeroen P J Saeij

Abstract read
In one paragraph

Article in International journal for parasitology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Microorganisms · 2026
    Review
  2. Article
  3. Article
  4. NcROP2 deletion reducesFrontiers in immunology · 2025
    Article
  5. Article
  6. TaqMan-quantitative PCR assays applied inFrontiers in cellular and infection microbiology · 2024
    Article
  7. NcPathogens (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Effects of Dense Granular Protein 6 (GRA6) Disruption onFrontiers in veterinary science · 2020
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

David Arranz-SolísDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, One Shields Ave., Davis 95616, CA, USA.
Javier Regidor-CerrilloSALUVET, Animal Health Department, Veterinary Faculty, Complutense University of Madrid, Avda. Puerta de Hierro s/n, 28040 Madrid, Spain.
Sebastian LouridoWhitehead Institute for Biomedical Research, Cambridge, MA 02140, USA.
Luis Miguel Ortega-MoraSALUVET, Animal Health Department, Veterinary Faculty, Complutense University of Madrid, Avda. Puerta de Hierro s/n, 28040 Madrid, Spain.
Jeroen P J SaeijDepartment of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, One Shields Ave., Davis 95616, CA, USA. Electronic address: jsaeij@ucdavis.edu.

Funding

Toxoplasma strain-specific modulation of mouse immune cellsR01AI080621 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SAEIJ, JEROEN · 2009 to 2018
$3.6M
NIAID NIH HHS R01 AI080621
6 · The paper itself

Abstract

Herein we describe, to our knowledge for the first time the use of the clustered regularly interspaced short palindromic repeats/CRISPR-associated gene 9 (CRISPR/Cas9) system for genome editing of Neospora caninum, an apicomplexan parasite considered one of the main causes of abortion in cattle worldwide. By using plasmids containing the CRISPR/Cas9 components adapted to the closely related parasite Toxoplasma gondii, we successfully knocked out a green fluorescent protein (GFP) in an Nc-1 GFP-expressing strain, and efficiently disrupted the NcGRA7 gene in the Nc-Spain7 isolate by insertion of a pyrimethamine resistance cassette. The successful use of this technology in N. caninum lays the foundation for an efficient, targeted gene modification tool in this parasite.

Indexed as

CRISPR-Cas SystemsDNA, HelminthDNA, ProtozoanGene EditingNeosporaPlasmidsToxoplasmaDNA, HelminthDNA, ProtozoanCRISPR/Cas9Gene disruptionNcGRA7Nc-Spain7Neospora caninumTransfection

Identifiers

PMID29625127
PMCPMC7025762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.